Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/10258| Title: | Elexacaftor/tezacaftor/ivacaftor in children aged ≥6 years with cystic fibrosis heterozygous forF508deland a minimal function mutation: Results from a 96-week open-label extension study | Authors: | Marcus A. Mall Claire E. Wainwright Julian Legg Mark Chilvers Sylvia Gartner Anna-Maria Dittrich Florian Stehling Sarah Conner Sebastian Grant Nina Suresh Tanya G. Weinstock Jane C. Davies |
Issue Date: | 10-Apr-2025 | Journal: | European Respiratory Journal |
| Appears in Sites: | Publication workflow Queensland Health Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.